biotech insider buying

biotech insider buying Articles

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge share purchases.
Insiders have been showing their love for these four biotech stocks, and one tech stock, lately with huge share purchases.
Insiders are still scooping up shares of certain stocks, including huge buys at two energy companies, an apparel retailer, and a biotech firm.
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the past week.
Biotech companies saw the most notable insider purchases of the past week. A Mexican billionaire also continued to build a stake.
The most notable insider purchases of the past week came from return buyers, including Warren Buffett. Another biotech IPO also tempted insiders to scoop up some shares.
Insider buying surged in February. Warren Buffett continues to build a stake in a media stock, and initial and secondary offerings tempted other insiders.
With the earnings-reporting season underway, insider buying has been slow. Yet some return buyers continue to build stakes, including huge new purchases in the past week.
The number of notable insider purchases has slowed since the beginning of the year. Yet one huge buy in the past week stood out.
Berkshire Hathaway came back this past week to load up on one particular tech stock. Meanwhile, other insiders were acquiring shares of a pair of biotech stocks.
Warren Buffett has been trimming stakes lately. So it was a bit of a surprise to see three huge insider purchases from Berkshire Hathaway late last week.
The most notable insider purchases of stock in the past week were in biotech and energy companies, as well as a specialty retailer.
The past week brought some huge insider share purchases, including a contrarian buy at an e-commerce platform operator and another at a troubled satellite provider.
Warren Buffett again boosted his stake in the newly independent Sirius XM. A biotech IPO prompted huge insider buying as well.
Warren Buffett again boosted his stake in the newly independent Sirius XM. Biotech stocks continue to prompt notable insider buying as well.